Generic Name and Formulations:
Butenafine HCl 1%; crm.
Indications for MENTAX:
Tinea versicolor, t. corporis, t. cruris, and interdigital t. pedis.
Apply to affected and immediately surrounding area. T. versicolor, corporis, cruris: Apply once daily for 2 wks. T. pedis: Apply twice daily for 1 wk, or once daily for 4 wks. Reevaluate if no improvement after therapy.
Avoid eyes, nose, mouth, mucous membranes. Do not occlude. Discontinue if irritation develops and confirm diagnosis. Sensitivity to allylamines. Pregnancy (Cat.B). Nursing mothers.
Burning/stinging, worsening of condition, other local irritation.
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- HbA1c Levels Predictive of Liraglutide Treatment Response in T2D
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine